CClinicalTrials.gg
CompletedNCT05571449Updated Sep 25, 2026

Efficacy of the Use of 3D Printing Models in the Treatment of Tibial Plateau Fractures: a Randomized Clinical Trial

An interventional study of Open reduction and internal fixation and Standard osteosynthesis planning in Tibial Plateau Fracture, sponsored by Pedro-José Torrijos-Garrido. Completed at 1 site in Spain. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Pedro-José Torrijos-Garrido · Not applicable, Interventional, and Treatment

Updated Sep 25, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

TIBIA3D is a randomized, open and prospective clinical trail that evaluates the use of preoperative 3D printing in the surgical treatment of patients with tibial plateau fractures

Read the detailed description

Randomized, open and prospective study.

Once the surgical indication for osteosynthesis has been established after having suffered a tibial plateau fracture, the patients will be randomized in a 1:1 ratio to one of the tfollowing treatment groups:

Control group: images obtained by plain radiography and computed tomography are used in the planning of osteosynthesis of the tibial plateau fracture.

Experimental group: in the planning of tibial plateau fracture osteosynthesis, in addition to images obtained by plain radiography and computed tomography, a three-dimensional plastic model printed by processing the tomography images is used.

Patients (or their legal representatives) must sign the consent before randomization.

After surgery, a follow-up will be carried out at 3, 6 and 12 months, visits in which data will be collected regarding the physical examination, radiological examination, pain and questionnaires will be filled out regarding the functionality of the knee and perception of health status.

02

Conditions studied

  • Tibial Plateau Fracture

Keywords

  • 3D printing
  • Tibial fracture
03

In context

Tibial Plateau Fractures

32 studies on the registry are indexed under Tibial Plateau Fractures; 9 are open to participants now.

This study's enrollment of 35 is below the median of 44 across 20 interventional studies indexed under Tibial Plateau Fractures.

Browse Tibial Plateau Fractures studies →

Lead sponsor

Pedro-José Torrijos-Garrido is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with tibial plateau fracture requiring surgical treatment.
  • Age equal to or greater than 18 years.
  • Signature of informed consent in writing according to current legislation before collecting any information.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy in progress.
  • Presence of serious systemic pathology or another situation that contraindicates treatment
  • Presence of other fractures in the ipsilateral femur or tibia that condition the surgical treatment of the tibial plateau fracture.
  • Findings in the physical examination, in the results of the tests or other medical, social or psychopathological factors that, in the opinion of the investigators, could negatively influence the study.
  • Inability to grant informed consent in the absence of a legal representative.
  • Inability to follow instructions or collaborate during the development of the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Experimental group

    Planning of tibial plateau fracture osteosynthesis by using a three-dimensional model of the fracture.

    Procedure: Open reduction and internal fixation · Procedure: Standard osteosynthesis planning · Procedure: 3-D model osteosynthesis planning

  • Other
    Control group

    Standard planning of tibial plateau fracture osteosynthesis (by plain radiography and computed tomography imaging).

    Procedure: Open reduction and internal fixation · Procedure: Standard osteosynthesis planning

Interventions

  • ProcedureOpen reduction and internal fixation

    Internal fixation of the fracture

  • ProcedureStandard osteosynthesis planning

    Plain radiograph and CT images are used

  • Procedure3-D model osteosynthesis planning

    A 3D plastic model made from CT images is used

06

What researchers measure

Primary outcomes

  1. Surgical time

    Surgical time will include the time from skin incision to wound closure

    Time frame: Week 1

  2. Fluoroscopy time.

    Intraoperative fluoroscopy time will be counted after incision and before wound closure.

    Time frame: Week 1

Secondary outcomes

  1. Ease of surgical planning with 3d printing

    Form filled out by the surgeon before the intervention to find out if the three-dimensional impression of the fracture has changed from the original preoperative planning that it had previously

    Time frame: Week 1

  2. Complications

    The incidence of complications, such as superficial wound infection, deep wound infection, iatrogenic neurological symptoms, reduction loss and fixation failure, will be recorded in both groups.

    Time frame: Week 1 - 12 months

Other outcomes

  1. Visual Analogis Scale for Pain

    VAS measure the intensity of the pain that the patient describes. It consists of a horizontal line of 10 centimeters, with 0cm being "no pain" and 10cm being "extreme pain".

    Time frame: 6 weeks - 12 months

  2. KOOS Questionarie

    The Knee injury and Osteoarthritis Outcome Score (KOOS) has been developed as an instrument to assess the patient's opinion about their knee and associated problems It has to separate sections ("Knee Score" and "Functional Score") that are scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.

    Time frame: 6 weeks - 12 months

  3. EuroQol-5D Questionarie

    Generic instrument for measuring health-related quality of life, in which the individual himself assesses his health status (0-100 score)

    Time frame: 6 weeks - 12 months

  4. WOMAC Questionarie

    It is the most widely used questionnaire to assess the results after knee and hip arthroplasty in patients with osteoarthritis in the lower extremity (0-68 score)

    Time frame: 6 weeks - 12 months

07

Study locations

1 site
  • Hospital Universitario Puerta de Hierro Majadahonda
    Majadahonda, Madrid 28222, Spain
08

References and documents

Publications

  • Garcia Cantarero M, Torrijos Garrido PJ, de Caceres Velasco AI, Sanchez Mallo O. Efficacy of the use of 3D printing models in the treatment of tibial plateau fractures: a pilot randomized clinical trial. J Orthop Surg Res. 2026 May 13;21(1):419. doi: 10.1186/s13018-026-06950-w. PubMed 42129866 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Sep 25, 2026
Primary completion
Oct 1, 2024→Nov 6, 2024 (actual)
Sep 25, 2026
Study completion
Oct 1, 2025→Nov 6, 2024 (actual)
Sep 25, 2026
Enrollment
30 (estimated)→35 (actual)
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Recruiting→Completed
    Primary completion Oct 1, 2024→Nov 6, 2024 (now actual)
    Study completion Oct 1, 2025→Nov 6, 2024 (now actual)
    Enrollment 30 (estimated)→35 (actual)
    + 5 other changes: index terms, verification date, contact details, site details and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05571449
Lead sponsor
Pedro-José Torrijos-Garrido
Responsible party
Pedro-José Torrijos-Garrido (Principal Investigator, Puerta de Hierro University Hospital) — Sponsor-investigator
First posted
Oct 7, 2022
Start date
Oct 1, 2022
Primary completion
Nov 6, 2024
Completion
Nov 6, 2024
Last update
Sep 25, 2026

Study contacts

Pedro J Torrijos Garrido, MD, PhD
principal investigator · Hospital Universitario Puerta de Hierro

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion